You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anaplastic mixed glioma

Showing 1 - 25 of 4,654
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Brain Tumor, Recurrent, Glioblastoma, Anaplastic Astrocytoma Trial in New York (Cytoreductive surgery, Perifosine, Temsirolimus)

Active, not recruiting
  • Brain Tumor, Recurrent
  • +4 more
  • Cytoreductive surgery
  • +2 more
  • New York, New York
  • +1 more
Jun 9, 2022

Glioma, Pilocytic Astrocytoma, Anaplastic Astrocytoma Trial in Saint Louis (MRI-guided laser ablation, Doxorubicin, Etoposide)

Recruiting
  • Glioma
  • +8 more
  • MRI-guided laser ablation
  • +4 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 22, 2022

Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma Trial in Rochester (procedure,

Active, not recruiting
  • Adult Anaplastic Astrocytoma
  • +15 more
  • biopsy
  • +7 more
  • Rochester, Minnesota
    Mayo Clinic
Apr 8, 2022

Anaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Oligodendroglioma Trial in United States (other, drug, procedure)

Active, not recruiting
  • Anaplastic Astrocytoma
  • +6 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Los Angeles, California
  • +11 more
Jul 1, 2022

Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Diffuse Astrocytoma Trial in New York (other, drug,

Completed
Has Results
  • Adult Anaplastic Astrocytoma
  • +8 more
  • Laboratory Biomarker Analysis
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jun 28, 2021

Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma, Mixed Glioma Trial in Minneapolis, Portland (Carboplatin, Etoposide,

Completed
  • Anaplastic Oligoastrocytoma
  • +3 more
  • Minneapolis, Minnesota
  • +1 more
Mar 11, 2022

Glioma, Mixed, Mild Neurocognitive Disorder Trial (C-SMART)

Not yet recruiting
  • Glioma, Mixed
  • Mild Neurocognitive Disorder
  • C-SMART
  • (no location specified)
Aug 11, 2023

Glioblastoma, Anaplastic Astrocytoma, Astrocytoma Trial in New York (Adaptive Radiotherapy)

Recruiting
  • Glioblastoma
  • +3 more
  • Adaptive Radiotherapy
  • New York, New York
    Columbia University Irving Medical Center
Oct 27, 2023

Recurrent High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial (PCI 24781, Temozolomide)

Not yet recruiting
  • Recurrent High Grade Glioma
  • +4 more
  • (no location specified)
Jan 24, 2023

Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Duarte, Chicago (Neural stem cells loaded with an

Completed
Has Results
  • Glioma
  • +7 more
  • Neural stem cells loaded with an oncolytic adenovirus
  • Duarte, California
  • +1 more
Dec 28, 2022

Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children,

Not yet recruiting
  • Anaplastic Astrocytoma
  • +17 more
    • (no location specified)
    Jun 28, 2023

    Glioblastoma Multiforme, Anaplastic Astrocytoma, Fibrillary Astrocytomas Trial in Miami (SIACI of cetuximab and bevacizumab)

    Not yet recruiting
    • Glioblastoma Multiforme
    • +4 more
    • SIACI of cetuximab and bevacizumab
    • Miami, Florida
      Jackson Memorial Hospital
    Jul 14, 2023

    Medulloblastoma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Buffalo, New York, Cincinnati (SurVaxM for patients

    Recruiting
    • Medulloblastoma
    • +7 more
    • SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years
    • +2 more
    • Buffalo, New York
    • +2 more
    Jul 8, 2022

    Adult Gliomas, Mixed Trial in San Francisco (Hyperpolarized Carbon 13 Alpha-ketoglutarate (HP C13-aKG), Magnetic Resonance Image

    Recruiting
    • Adult Gliomas, Mixed
    • Hyperpolarized Carbon 13 Alpha-ketoglutarate (HP C13-aKG)
    • Magnetic Resonance Image (MRI)
    • San Francisco, California
      University of California, San Francisco
    May 9, 2023

    Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Miami (biological, drug, procedure)

    Completed
    • Malignant Glioma
    • +3 more
    • Dendritic Cell Vaccine
    • +3 more
    • Miami, Florida
      University of Miami
    Jul 19, 2022

    Tumors, High Grade Glioma, Glioblastoma Multiforme Trial in Birmingham (Biological G207)

    Not yet recruiting
    • Neoplasms
    • +7 more
    • Biological G207
    • Birmingham, Alabama
      Children's of Alabama
    Jun 1, 2022

    Glioma, Malignant, High Grade Glioma, Glioblastoma Trial in Tampa (OS2966, Gadoteridol)

    Active, not recruiting
    • Glioma, Malignant
    • +4 more
    • Tampa, Florida
      Moffitt Cancer Center
    Nov 28, 2022

    Oligodendroglioma, Astrocytoma, Grade II, Glioma, Astrocytic Trial in San Francisco (GBM6-AD and poly-ICLC before and after

    Active, not recruiting
    • Oligodendroglioma
    • +5 more
    • GBM6-AD and poly-ICLC before and after surgery
    • GBM6-AD and poly-ICLC after surgery only
    • San Francisco, California
      University of California
    Sep 20, 2022

    Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

    Withdrawn
    • Recurrent Anaplastic Astrocytoma
    • +7 more
    • Neural Stem Cells-expressing CRAd-S-pk7
    • Resection
    • (no location specified)
    Nov 22, 2022

    Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma Trial in New York (Intra-arterial Cetuximab, Intra-arterial

    Recruiting
    • Glioblastoma
    • +8 more
    • Intra-arterial Cetuximab
    • +2 more
    • New York, New York
      Lenox Hill Brain Tumor Center
    Oct 17, 2022

    Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,

    Recruiting
    • Anaplastic Astrocytoma, IDH-Wildtype
    • +8 more
    • Quality-of-Life Assessment
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 8, 2022

    Recurrent High-grade Glioma, Recurrent Glioblastoma, Recurrent Anaplastic Astrocytoma Trial in Incheon (500mg/kg/3hr followed by

    Recruiting
    • Recurrent High-grade Glioma
    • +3 more
    • 500mg/kg/3hr followed by neutron irradiation to reach maximum brain dose of 9Gy-Eq
    • +2 more
    • Incheon, Korea, Republic of
      Gachon University Gil Medical Center
    Feb 19, 2023

    Targeted Pediatric High-Grade Glioma Therapy

    Not yet recruiting
    • High Grade Glioma
    • +8 more
      • Aurora, Colorado
      • +17 more
      May 1, 2023

      Diffuse Intrinsic Pontine Glioma, Malignant Glioma of Brain, High Grade Glioma Trial in United States (ribociclib, Everolimus)

      Completed
      • Diffuse Intrinsic Pontine Glioma
      • +6 more
      • Washington, District of Columbia
      • +6 more
      Jan 12, 2023

      Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in United States (INCB7839)

      Recruiting
      • Glioblastoma Multiforme
      • +5 more
      • Los Angeles, California
      • +12 more
      Jan 9, 2023